Skip to main content
. 2014 Dec 1;33(13):1430–1437. doi: 10.1200/JCO.2014.59.0703

Fig A1.

Fig A1.

Changes in measurable lesions from study baseline in patients treated beyond progression (n = 36 [0.3 mg/kg, n = 10; 2 mg/kg, n = 12; 10 mg/kg, n = 14]). Circles represent assessments that occurred after initial progression.